Enhancement of intestinal mucosal immunity and immune response to the foot-and-mouth disease vaccine by oral administration of danggui buxue decoction

Bingxin Zhou,Huan Huang,Fuxing Gui,Shicheng Bi,Hongxu Du,Liting Cao
DOI: https://doi.org/10.3389/fvets.2022.1045152
IF: 3.471
2022-11-08
Frontiers in Veterinary Science
Abstract:This study investigated the effect of Danggui Buxue decoction (DBD) on the immunity of an O-type foot-and-mouth disease (FMD) vaccine and intestinal mucosal immunity. SPF KM mice were continuously and orally administered DBD for 5 d and then inoculated with an O-type FMD vaccine. The contents of a specific IgG antibody and its isotypes IgG1, IgG2a, IgG2b, and IgG3 in serum and SIgA in duodenal mucosa were determined by ELISA at 1 and 3 W after the 2 nd immunization. qRT-PCR was used to detect mRNA expression levels of IL-4, IL-10, IFN-γ, and IL-33 in the spleen, and mRNA expression levels of J-chain, pIgR, BAFF, APRIL, IL-10, IFN-γ and IL-33 in the duodenum. The results showed that compared with the control group, oral administration of DBD significantly increased levels of the anti-FMD virus (FMDV)-specific antibodies IgG, IgG1, and IgG2a in the serum of O-type FMD vaccine-immunized mice 1 W after the 2 nd immunization ( P < 0.05 ), upregulated mRNA expression levels of spleen lymphocyte cytokines IL-4 and IL-33 ( P < 0.05 ), promoted the secretion of SIgA in duodenal mucosa ( P < 0.05 ). The mRNA expression levels of J-chain, pIgR, BAFF, APRIL, IL-10, and IL-33 in duodenal tissues were upregulated ( P < 0.05 ). This study indicates that DBD has a good promotion effect on the O-type FMD vaccine and the potential to be an oral immune booster.
veterinary sciences
What problem does this paper attempt to address?